NCI budget: a “Yes” to one thing means a “No” to something else, director says.
Also in this 8-page issue: Bush nominates McClellan to head CMS.
FDA to refer false statements by regulated companies to SEC.
Sandra Horning elected ASCO president-elect.
Medicare coverage and quality of care top ASCO’s list of policy priorities for 2004.
NIH appoints panel to review conflict of interest rules.
Funding opportunities listed.
PDF file includes 8-page February issue of Business & Regulatory Report.
Trending Stories
- Imaging’s ride to the bottom in clinical trials—and why it matters now
- In the Headlines: Is oncology ready to move away from animal testing?
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
- The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic - NIH says it’s moving away from animal-based models